About the Author
Dr. Alonso is a graduate of Princeton University and the University of Florida College of Medicine. He served as a surgeon during the VietNam War and was instrumental in creating the first drug rehabilitation center in the Theater of Operations. Dr. Alonso completed training in pathology and in nuclear medicine at the Fitzsimons Army Medical Center in Denver. He is a graduate of the Command and General Staff School.
Dr. Alonso has broad experience in both clinical and laboratory medicine. As Chief Operating Officer of a wholly-owned subsidiary of The Upjohn Company he personally led the effort to adapt and validate the estrogen receptor assay which enabled the test to become widely used to predict breast cancer response and to guide breast cancer therapy. Dr. Alonso was elected a Fellow of the prestigious American College of Physicians during this period.
Dr. Alonso holds world-wide patents on the creation of human-human hybridomas and their use to generate monoclonal antibodies directed against tumor surface antigens for the diagnosis and treatment of cancer. The process entails creation of a fourth, new human cell, from three different human donors and maintaining the life of that fourth cell indefinitely as it is manipulated to produce protein products for human use.
Dr. Alonso has published extensively on the use of cellular products and of heat to alter human immunologic responses. Long term favorable cellular changes in patients with cancer and with AIDS have been shown with these approaches.
Dr. Alonso has also served as Chief Medical Examiner for the State of Georgia at the Georgia Bureau of Investigation and is the author of a textbook on forensic pathology.
Presently Dr. Alonso is engaged in an apostolate involving patients with cancer and AIDS, directing public education efforts, clinical trials, and providing free second opinions to assist others in obtaining optimal care. The effort is world-wide; staffed entirely by volunteers; and funded through private donations.
